Highlights
NASDAQ: AKCA       Akcea Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
18.17   0.00 (0.00%)  18.14 - 18.17  815,384

Overview

 
Avg Volume (4 weeks):715,020
4 Weeks Range:18.08 - 18.17
4 Weeks Price Volatility (%):
100.00%
52 Weeks Range:8.00 - 21.705
52 Weeks Price Volatility (%):
74.21%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1994  6612  492  172 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MGEN 1.26+0.74 
 TTNP 0.167+0.039 
 GE 7.42+0.32 
 AAPL 111.20-5.40 
 SPY 326.66-11.56 
 SQQQ 24.65+2.59 
 UVXY 23.14+4.07 
 NIO 27.51-0.93 
 XLF 23.61-0.62 
 F 7.70-0.22